Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a solution for injection for intraarterial, intraarticular, and intravenous use. It provides radiodensity enhancement that facilitates clear visualization of vascular and tissue structures during diagnostic imaging procedures such as angiography, arthrography, computed tomography and other vascular imaging studies.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Iomeron, an iodinated contrast agent, enhances radiographic visualization in several diagnostic imaging procedures.

Angiography: improves delineation of blood vessels for accurate assessment. Arthrography: highlights joint spaces to aid evaluation of cartilage and ligaments. Computed tomography (CT) imaging: increases tissue contrast for detailed cross‑sectional images. Vascular imaging procedures: accentuates vascular anatomy for precise diagnosis.

Iomeron may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Warm sensation or flushing: transient feeling of heat during injection. - Metallic taste: brief alteration of taste perception. - Nausea: mild upset stomach. - Headache: mild to moderate pain.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate treatment. - Renal toxicity: impaired kidney function, especially in patients with pre‑existing renal disease. - Severe hypotension: sudden drop in blood pressure. - Cardiac arrhythmia: irregular heart rhythm.

When using Iomeron, several precautions should be observed to minimize risk and ensure patient safety. - Assess renal function: evaluate eGFR before administration in patients with kidney disease. - Review allergy history: avoid use in individuals with prior severe reactions to iodinated contrast. - Ensure adequate hydration: provide sufficient fluids before and after the procedure to support renal clearance. - Use the lowest effective volume: limit contrast dose to the minimum required for diagnostic quality. - Monitor vital signs: observe patients during and after injection for signs of hypotension or allergic response. - Store at ambient temperature: keep in original container, protect from light and moisture, and do not freeze.

Iomeron can interact with certain medications, influencing safety or efficacy.

Major Interactions (Avoid): - Nephrotoxic drugs (e.g., aminoglycosides, NSAIDs): increase risk of renal impairment. - Metformin: may precipitate lactic acidosis in patients with reduced renal function after contrast exposure. - Iodine‑containing pharmaceuticals (e.g., amiodarone): add to total iodine load.

Moderate Interactions (Monitor Closely): - Diuretics: affect fluid balance and may potentiate contrast‑induced nephropathy. - ACE inhibitors or ARBs: may alter renal hemodynamics, requiring monitoring of kidney function.